Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Grace Therapeutics, Inc. (GRCE) had Free Cash Flow per Share of $-1.04 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-4.16M |
|
-- |
|
-- |
|
$3.70M |
|
$-3.70M |
|
$-1.06M |
|
$-4.76M |
|
$-4.76M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-3.70M |
|
$-3.70M |
|
11.51M |
|
11.51M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$11.94M |
|
$0.02M |
|
$49.28M |
|
$61.22M |
|
$1.97M |
|
-- |
|
$7.11M |
|
$9.09M |
|
$52.14M |
|
$2.87M |
|
$52.14M |
|
10.14M |
|
| Cash Flow Statement Financials | |
$-11.95M |
|
$0.00M |
|
-- |
|
$23.00M |
|
$11.05M |
|
$-11.95M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.97% |
|
-144.62% |
|
-6.79% |
|
-7.97% |
|
$5.14 |
|
|
Free Cash Flow per Share |
$-1.04 |
$-1.04 |
|